VXLLF
VAXIL BIO LTD CDA by Vaxil Bio Ltd. (VXLLF)
$02
About VAXIL BIO LTD CDA by Vaxil Bio Ltd. (VXLLF)
Vaxil Bio Ltd. is a biotechnology company engaged in the development of signal peptide-based immunotherapies for the treatment of cancer and infectious diseases. Its pipeline consists of ImMucin, SPmAb2, SPmAb6, and MTbuVax. The company was founded on July 26, 2006 and is headquartered in Toronto, Canada.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.50
52 Week Low
$0.00
Market cap
88,000
Dividend yield
0.00%
Volume
--
Avg. volume
6
P/E ratio
.25
VAXIL BIO LTD CDA by Vaxil Bio Ltd. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.50
52 Week Low
$0.00
Market cap
88,000
Dividend yield
0.00%
Volume
--
Avg. volume
6
P/E ratio
.25